2022
Hybridization Approach to Identify Salicylanilides as Inhibitors of Tubulin Polymerization and Signal Transducers and Activators of Transcription 3 (STAT3)
GARGANTILLA, Marta, Leentje PERSOONS, Tereza KAUEROVÁ, Natalia DEL RIO, Dirk DAELEMANS et. al.Základní údaje
Originální název
Hybridization Approach to Identify Salicylanilides as Inhibitors of Tubulin Polymerization and Signal Transducers and Activators of Transcription 3 (STAT3)
Autoři
GARGANTILLA, Marta, Leentje PERSOONS, Tereza KAUEROVÁ (203 Česká republika, domácí), Natalia DEL RIO, Dirk DAELEMANS, Eva-Maria PRIEGO, Peter KOLLÁR (203 Česká republika, garant, domácí) a Maria-Jesus PEREZ-PEREZ
Vydání
Pharmaceuticals, BASEL, MDPI, 2022, 1424-8247
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.600
Kód RIV
RIV/00216224:14160/22:00126409
Organizační jednotka
Farmaceutická fakulta
UT WoS
000833255500001
Klíčová slova anglicky
tubulin polymerization inhibitors; colchicine site; salicylanilides; niclosamide; signal transducer and activator of transcription (STAT3) inhibitors
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 11. 8. 2022 07:41, JUDr. Sabina Krejčiříková
Anotace
V originále
The superimposition of the X-ray complexes of cyclohexanediones (i.e., TUB015), described by our research group, and nocodazole, within the colchicine binding site of tubulin provided an almost perfect overlap of both ligands. This structural information led us to propose hybrids of TUB015 and nocodazole using a salicylanilide core structure. Interestingly, salicylanilides, such as niclosamide, are well-established signal transducers and activators of transcription (STAT3) inhibitors with anticancer properties. Thus, different compounds with this new scaffold have been synthesized with the aim to identify compounds inhibiting tubulin polymerization and/or STAT3 signaling. As a result, we have identified new salicylanilides (6 and 16) that showed significant antiproliferative activity against a panel of cancer cells. Both compounds were able to reduce the levels of p-STAT3(Tyr705) without affecting the total expression of STAT3. While compound 6 inhibited tubulin polymerization and arrested the cell cycle of DU145 cells at G2/M, similar to TUB015, compound 16 showed a more potent effect on inhibiting STAT3 phosphorylation and arrested the cell cycle at G1/G0, similar to niclosamide. In both cases, no toxicity towards PBMC cells was detected. Thus, the salicylanilides described here represent a new class of antiproliferative agents affecting tubulin polymerization and/or STAT3 phosphorylation.